Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay Validation
Recognizing an increasing need for biomarkers that predict clinical outcomes in type 1 diabetes (T1D), JDRF, a major funding organization for T1D research, recently instituted the Core for Assay Validation (CAV) to accelerate the translation of promising assays from discovery to clinical implementat...
Main Authors: | Speake, Cate, Odegard, Jared M. |
---|---|
Format: | Online |
Language: | English |
Published: |
Libertas Academica
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589091/ |
Similar Items
-
The Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor Types
by: Linsley, Peter S., et al.
Published: (2015) -
Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma
by: Daugaard, Iben, et al.
Published: (2016) -
Validation of biomarkers of food intake—critical assessment of candidate biomarkers
by: L. O. Dragsted, et al.
Published: (2018-05-01) -
Assay Validation for KIM-1: human urinary renal dysfunction biomarker
by: Shalini Chaturvedi, Takeisha Farmer, Gordon F. Kapke
Published: (2009-01-01) -
Recognition of Posttranslationally Modified GAD65 Epitopes in Subjects With Type 1 Diabetes
by: McGinty, John W., et al.
Published: (2014)